Marker Therapeutics (MRKR) Other Non Operating Income (2010 - 2026)
Marker Therapeutics (MRKR) posted quarterly Other Non Operating Income of $8677.0 for Q1 2026, down 92.61% quarter-over-quarter from $117444.0 in Q2 2025.
Marker Therapeutics (MRKR) Other Non Operating Income (2010 - 2026) Analysis & Trends
Marker Therapeutics (MRKR) has reported Other Non Operating Income for 13 consecutive years, with $8677.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non Operating Income changed N/A year-over-year to $8677.0; the TTM figure through Mar 2026 stood at $126121.0 (changed N/A YoY), while the FY2025 annual figure was $117444.0, changed N/A from the prior year.
- Other Non Operating Income eased to $8677.0 in Q1 2026 per MRKR's latest filing, from $117444.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $117444.0 in Q2 2025 and bottomed at $8677.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Marker Therapeutics | 27.04 Mn | 15.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,677.00 |
| Jun 30, 2025 | 117,444.00 |
| Mar 31, 2020 | 31,000.00 |
| Dec 31, 2019 | 98,000.00 |
| Sep 30, 2019 | -64,000.00 |
| Jun 30, 2019 | -7,000.00 |
| Mar 31, 2019 | -9,000.00 |
| Dec 31, 2018 | 58,000.00 |
| Sep 30, 2018 | 40,000.00 |
| Jun 30, 2018 | -139,000.00 |
| Mar 31, 2018 | 1,000.00 |
| Dec 31, 2017 | 483,865.00 |
| Sep 30, 2017 | 4,000.00 |
| Jun 30, 2017 | 495,365.00 |
| Mar 31, 2017 | -3,000.00 |
| Dec 31, 2016 | 5.94 Mn |
| Sep 30, 2016 | -5.24 Mn |
| Jun 30, 2016 | -70,315.00 |
| Mar 31, 2016 | -3.00 Mn |
| Dec 31, 2015 | 613,000.00 |